Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Hemostemix HMTXF


Primary Symbol: V.HEM

Hemostemix Inc is a clinical-stage biotechnology company. The company's principal business activity is to develop, manufacture, and commercialize blood-derived cell therapies for medical conditions. Its technology platform for developing autologous cell therapies is for the treatment of vascular diseases. The group's clinical-stage candidate, ACP-01, is an autologous cell therapy for the treatment of critical limb ischemia.

The Power Play by The Market Herald
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Stock Price Chart (OTCQB:HMTXF)

Fundamentals Snapshot (OTCQB:HMTXF)

Bullboard Posts (TSXV:HEM)

RE:RE:RE:RE:RE:RE:ACP-01 Midpoint Analysis

Also if I were Aspire and knew I had put out misleading info for which i could be held liable I would definitely hold on to the evidence...
WalterTheDawg - 1 day ago

RE:RE:RE:RE:RE:ACP-01 Midpoint Analysis

Ya that would be fraud you would think and it has always made me second guess how this data will pan out. Then again, you wouldn't be...
WalterTheDawg - 1 day ago

RE:RE:RE:RE:ACP-01 Midpoint Analysis

Thanks for informative response. If Accudata and Aspire misrepresented the data, that would be fraud - no? But I see the court accepted...
FredZarfloon - 1 day ago

Moving Forward

Nice to see we are in full motion,I beleive we are in for a big ride anytime coming soon.GLA.--{Results are not that far off and we can...
Boxcar1964 - 1 day ago

Proceeds to commence buildout of production ACP-01

Proceeds from the Offering are expected to be used to pay finder fees payable in connection with the closing, current filing and...
Blendedman - 1 day ago

PP

They are still needing new cash!!! Man this is going to be a while yet until they release the results! 
ENEMENEMYNEMO - 1 day ago